Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: sim1 who wrote (1041)	7/9/1999 11:50:00 PM
From: Walkingshadow	Respond to of 1073

Stuart--- Thanks for the post, and the abstract. Although I have not yet seen the article, note the first sentence in the abstract: The mitogen-activated protein kinase pathway is thought to be essential* in cellular growth and differentiation.* Given this, I would anticipate significant side effects/toxicity. However, these investigators report that there were none. Intriguing, but, given the fundamental importance of this pathway, I am skeptical that results in humans would be similarly free of side effects/toxicity. But, of course, that remains to be seen one way or another..... Another development which bears watching, but (in IMHO) watching only at this point.... Thanks again Walkingshadow